prnewswire.com

Reputation Factor: 3.81 High
Sites Owned: 4
Total Reference Links: 717
Total Citations: 757
Unique Wikipedia Articles Citing: 628

Associated Sites

mma.prnewswire.com

Uncategorized

Links: 1

Citations: 1

prnewswire.com

Uncategorized

Links: 1

Citations: 1

www.prnewswire.com

News

Links: 714

Citations: 754

www2.prnewswire.com

Uncategorized

Links: 1

Citations: 1

Top Reference Links

Score	Article	Site	Category	Cited In (Articles)
15.2	Lightricks Releases LTX-2: The First Complete Open-Source AI Video Foundation Model https://www.prnewswire.com/news-releases/lightricks-releases-ltx-2-the-first-complete-open-source-ai-video-foundation-model-302593012.html	www.prnewswire.com	News	4
15.2	Civitas Group llc Expands Senior-Level Expertise with Addition of Andrew Weis and Douglas Callen https://www.prnewswire.com/news-releases/civitas-group-llc-expands-senior-level-expertise-with-addition-of-andrew-weis-and-douglas-callen-85953367.html	www.prnewswire.com	News	4
15.2	Andrew Weis Receives Promotion to Senior Vice President, Federal Civilian Business Unit https://www.prnewswire.com/news-releases/andrew-weis-receives-promotion-to-senior-vice-president-federal-civilian-business-unit-246031451.html	www.prnewswire.com	News	4
11.4	Novartis receives FDA approval for Rhapsido (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU) https://www.prnewswire.com/news-releases/novartis-receives-fda-approval-for-rhapsido-remibrutinib-the-only-oral-targeted-btki-treatment-for-chronic-spontaneous-urticaria-csu-302571629.html	www.prnewswire.com	News	3
11.4	U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer https://www.prnewswire.com/news-releases/us-fda-approves-inluriyo-imlunestrant-for-adults-with-er-her2-esr1-mutated-advanced-or-metastatic-breast-cancer-302567490.html	www.prnewswire.com	News	3
11.4	Clarivate Unveils Citation Laureates 2025 - Highlighting Nobel-Class Research with Global Impact https://www.prnewswire.com/news-releases/clarivate-unveils-citation-laureates-2025--highlighting-nobel-class-research-with-global-impact-302566388.html	www.prnewswire.com	News	3
11.4	Six Flags Over Texas Unveils Record-Breaking Roller Coaster 'Tormenta Rampaging Run;' Set to Become Tallest, Fastest, Longest and First-Ever Giga Dive Coaster https://www.prnewswire.com/news-releases/six-flags-over-texas-unveils-record-breaking-roller-coaster-tormenta-rampaging-run-set-to-become-tallest-fastest-longest-and-first-ever-giga-dive-coaster-302567286.html	www.prnewswire.com	News	3
7.6	Ailux Appoints Maria Belvisi, Ph.D., as Chief Scientific Officer https://www.prnewswire.com/news-releases/ailux-appoints-maria-belvisi-phd-as-chief-scientific-officer-302738847.html	www.prnewswire.com	News	2
7.6	Precigen Announces Full FDA Approval of Papzimeos (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis https://www.prnewswire.com/news-releases/precigen-announces-full-fda-approval-of-papzimeos-zopapogene-imadenovec-drba-the-first-and-only-approved-therapy-for-the-treatment-of-adults-with-recurrent-respiratory-papillomatosis-302530957.html	www.prnewswire.com	News	2
7.6	Terex and REV Group complete merger, creating a premier specialty equipment manufacturer https://www.prnewswire.com/news-releases/terex-and-rev-group-complete-merger-creating-a-premier-specialty-equipment-manufacturer-302675744.html	www.prnewswire.com	News	2

Citation Trends Over Time